DOI: 10.1200/jco.2016.69.1584 link
PMID: 28034081
OpenAlex ID: W2531934133
Category: Oncology
Title: Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-...
Authors: Tomasz M. Beer, Winald R. Gerritsen, Fábio Franke, Javier Puente, Roman Carvajal, Lisa Sengeløv, M. Brent McHenry, Arvind Varma,... (23 authors, truncated)
Publishing date: 01-Jan-2017
YCR = 2017 / 593 / 15.14
Version 1.00 Year / Citations / Relative
Metric | Value | Date of Calculation |
---|---|---|
Citations count |
593 |
30-May-2024 |
Relative |
15.14 |
04-Aug-2024 |
Article Expected CPY (Citations per Year): 5.60 Expected CPY Help
Article Actual CPY: 84.71 Actual CPY Help
Article Co-Citation FCR (Field Citation Rate): 7.67 FCR Help
Article Co-Citation Network Size: 52291 Co-Citation Network Size Help
Article Topics: Cancer Immunotherapy, Advancements in Prostate Cancer Research, Immunobiology of Dendritic Cells Topics help
Article Keywords: Metastatic Prostate Cancer, Prostate Cancer, Cancer Immunotherapy Keywords Help
Journal: Journal of clinical oncology
Journal IF-ycr: 1.644 Journal IF-ycr Help
Journal short code: NA
Journal ISSN: 0732-183X
Journal OA-ID: 15137598
Expected CPY Help: Predicted citations per year for this article, derived from its Field Citation Rate (FCR) using a benchmark regression of NIH-funded papers. Values above actual CPY indicate under-performance; below indicate over-performance. Used as the denominator of the Relative Citation Ratio.
Back to topActual CPY Help: Average yearly citations the article has received from publication through the current year, adjusted for partial years. Used as the numerator of the Relative Citation Ratio.
Back to topFCR Help: Mean journal citation rate for all papers in the article's co-citation network. For each network paper we substitute its journal’s impact factor (calculated from open data) as a proxy for citations per year, then average these values. This captures the citation intensity of the article's immediate research field and forms the basis for computing expected CPY.
Back to topCo-Citation Network Size Help: Number of unique papers co-cited with this article by its citing papers; larger networks yield more stable field estimates when calculating FCR and expected CPY.
Back to topTopics Help: OpenAlex assigns topics to each paper with an AI model that considers the title, abstract, journal, and citation links. Tags are chosen from about 4,500 research areas, and the highest-confidence tag becomes the paper's primary topic. Every topic sits in a hierarchy of domain, field, and subfield, so you can see exactly where the work fits in the wider map of science.
Back to topKeywords Help: Keywords are generated automatically from the paper's assigned topics. The OpenAlex system selects candidate terms, then keeps up to five that match closely with the title or abstract. These keywords highlight specific concepts or methods and give a quick complement to the broader topic tags.
Back to topJournal IF-ycr Help: Journal IF-ycr is a two-year impact factor recalculated from OpenAlex's open citation data. For a given journal and year Y, we:
- Count citations made in year Y by any paper to items that the journal published in years Y-1 and Y-2 (excluding the current year).
- Divide that citation count by the number of articles the journal published in those same two years.